Friday, January 17, 2014Wallaby Gets PCI CertificationPasadena-based financial startup Wallaby, the developer of apps to help consumers pick the best credit card for a specific purchase, said it has been certified by the Payment Card Industry (PCI) Security Standards Council, the group which oversees credit card industry security standards. Wallaby--which is also working on a physical credit card to virtually steer specific purchases to other credit cards--said the move is a "Significant benchmark" for the company. Wallaby is led by Matthew Goldman (More info...)
posted on Friday, January 17, 2014(Full story)
ValueClick Completes Sale Of Business UnitWestlake Village-based ValueClick said late Thursday that it has completed its sale of its Owned & Operated Websites segment, which included Investopedia, Pricerunner, as well as other websites. Financial details of the sale have not been announced. ValueClick announced the sale of the units to IAC in December.
posted on Friday, January 17, 2014(Full story)
FutureLogic Shuffles Executive TeamGlendale-based FutureLogic, the manufacturer of thermal ticket printing and other products, reported it has shuffled its senior leadership team Thursday. The company said that Eric Meyerhofer has replaced Miles Arone, who remains on the company's board, and that the company has named Peter Murphy as CEO and Nick Ortyle as Chief Operating Officer. Murphy was previously the company's COO, and previously served at Astrodyne, Parlex, and IPC. Ortyl joins the company from L-3 Communicaitons, where he (More info...)
posted on Friday, January 17, 2014(Full story)
Kite Pharma Names Regulatory VPLos Angeles-based Kite Pharma announced this morning that it has named a new VP. The biotechnology company--which is developing treatments for cancer--said it has named Rizwana F. Sproule, Ph.D. as Vice President, Regulatory Affairs. Sproule was previously at Amgen, including serving as Executive Director, Therapeutic Area Head for Oncology Global Regulatory Affairs. She also served at SmithKline Beecham Pharmaceuticals.
posted on Friday, January 17, 2014(Full story)
Southern California Startups Raise More Than $598.4M In VC In Q4
Southern California's venture capital investments totaled a little more than $598.4M in the fourth quarter, according to the latest number from PricewaterhouseCoopers and the National Venture Capital Association, in its MoneyTree report. The investments were a drop from Q4 of 2012, $711.8M was invested in the region. There were 84 venture capital deals for the quarter. For the year, a total of $2.51 billion was invested across Southern California's technology industry.
The largest financi (More info...)
posted on Friday, January 17, 2014(Full story)